$enGene Holdings(ENGN.US)$Shorts are going to cover this week due to such a high rate. There is also less than 400 shares available. Projected is 31.00 but that is after covering. They may wait until 50.00 to short it again unless lockup has ended for them, then they will sell.
The appointment of Lee Giguere, an experienced public biotech legal executive, is expected to strongly support enGene's growth as the company advances the development of EG-70 in its ongoing pivotal-stage LEGEND study in BCG-unresponsive non-muscle invasive bladder cancer.
MikeyMikeMike :
Talk to them. Tell them we need squeeeeeee...eeez to make money! I'm sure they will understand . Hey, I'm up 30+%. as much as I'd rather see 300%, in the green is good for me.
enGene Holdingsに関するコメント
まだコメントはありません